Shukra Pharmaceuticals Ltd.
NSE: SHUKRAPHAR | BSE: 524632
₹55.26
₹1.02
(1.88%)
As on 18-Sep-2026 11:29IST
Market cap
₹2,414 Cr
Revenue (TTM)
₹75 Cr
P/E Ratio
67
P/B Ratio
22
Div. Yield
0 %
Quality Score
4/10
Growth Score
6/10
Valuation Score
4/10
Momentum Score
9/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹36 Cr
-
ROE
15.9 %
-
ROCE
21.8 %
-
Industry P/E
45.78
-
EV/EBITDA
46
-
Debt to Equity
0.1
-
Book Value
₹2.5
-
EPS
₹0.8
-
Face value
1
-
Shares outstanding
440,787,440
10 Years Aggregate
CFO
₹19.18 Cr
EBITDA
₹49.28 Cr
Net Profit
₹35.10 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Shukra Pharma
| -- | 33.3 | -- | -- | -- | -- | -- |
|
BSE Healthcare
| 18.3 | 1.4 | 9.2 | 14.8 | 21.4 | 14.1 | 12.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Shukra Pharma
|
55.3 | 2,414.2 | 74.8 | 36.1 | 60.0 | 46.3 | 67 | 22.0 |
| 3,365.4 | 27,374.0 | 1,461.8 | 387.4 | 34.5 | 25.2 | 70.9 | 15.9 | |
| 851.2 | 16,584.0 | 7,784.0 | 688.5 | 10.6 | 14 | 23.9 | 2.8 | |
| 439.9 | 16,834.3 | 2,141.5 | 58.5 | 5.8 | 3.3 | 158.5 | 4.4 | |
| 884.0 | 24,171.0 | 5,632.3 | 662.4 | 17.2 | 14.3 | 36.5 | 4.9 | |
| 1,022.6 | 16,444.2 | 8,608.3 | 351.6 | 8.7 | 5.7 | 46.7 | 2.3 | |
| 1,594.0 | 18,581.6 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.2 | |
| 208.7 | 27,752.0 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.5 | |
| 1,807.7 | 29,961.3 | 1,935.8 | 288.2 | 20.6 | 29.8 | 104 | 22.3 | |
| 2,061.0 | 34,021.8 | 3,564.0 | 414.0 | 15.3 | 8.4 | 83.2 | 6.8 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Shukra Pharma
Manufacture of allopathic pharmaceutical preparations
-
Incorporated
1993
-
Chairman
--
-
Managing Director
Dakshesh Rameshchandra Shah
-
Headquarters
Ahmedabad, Gujarat
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Shukra Pharma
What is the current share price of Shukra Pharmaceuticals Ltd Today?
The share price of Shukra Pharmaceuticals Ltd is ₹55.26 (NSE) and ₹55.33 (BSE) as of 18-Sep-2026 11:29 IST. Shukra Pharmaceuticals Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Shukra Pharmaceuticals Ltd?
The P/E ratio of Shukra Pharmaceuticals Ltd is 66.97 times as on 18-Sep-2026, a 46 premium to its peers’ median range of 45.78 times.
The P/B ratio of Shukra Pharmaceuticals Ltd is 21.98 times as on 18-Sep-2026, a 400 premium to its peers’ median range of 4.40 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
99.91 |
15.23 |
2024 |
0.48 |
6.20 |
2023 |
1.04 |
0.73 |
2022 |
2.62 |
0.58 |
2021 |
7.71 |
0.45 |
What is the 52 Week High and Low of Shukra Pharmaceuticals Ltd?
The 52-week high and low of Shukra Pharmaceuticals Ltd are Rs 58.20 and Rs 40.06 as of 18-Sep-2026.
What is the market cap of Shukra Pharmaceuticals Ltd?
Shukra Pharmaceuticals Ltd has a market capitalisation of ₹ 2,414 Cr as on 18-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Shukra Pharmaceuticals Ltd?
Before investing in Shukra Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.